SNCA and Parkinson disease: GBA1 mutations reduce the enzymatic function of GCase, which may favor toxic accumulation of alpha-synuclein fibrils in the typical intra-neuronal inclusions (Lewy bodies) found throughout the central nervous system of PD patients (Balestrino and Schapira, 2018).